The Gunma Bank, Ltd. (8334.T)
Maebashi, JP
Gunma Bank, Ltd. is a Japanese financial institution that delivers a diverse array of banking and financial solutions across the nation. Its operations encompass fund management activities, such as investing in various securities and sourcing capital from the call money market. The bank also facilitates customer deposits, issues negotiable certificates of deposit, and extends a variety of loan products. Furthermore, Gunma Bank provides services like securities investment, lease financing, derivative transactions, and proprietary derivative trading. The company was established in 1932 and maintains its headquarters in Maebashi, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.90% | +0.83% | -3.63% | -1.79% | +36.21% | +24.17% | +82.13% | +339.08% | +513.73% | +433.09% | +291.95% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth+17.9% Q1'26: +18.6% (vs Q1'25)
-
EPS growth+36.1% Q1'26: +18.2% (vs Q1'25)
-
FCF margin— Q1'26: +0.0% (vs Q1'25)
-
EBIT margin— Q1'26: +31.7% (vs Q1'25)
-
ROIC— Q1'26: +9.1% (vs Q1'25)
-
Share dilution-1.5% Q1'26: -1.0% (vs Q1'25)
-
Debt / EBITDA— Q1'26: 17.49× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 2 EPS Ana. |
Mar 2027 1 Rev. Ana. 2 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
137.22B
est: 109.05B (+25.8%)
|
136.58B
est: 128.48B (+6.3%)
|
142.38B
est: 130.30B (+9.3%)
|
146.85B
est: 138.39B (+6.1%)
|
145.15B
est: 147.00B (-1.3%)
|
136.85B
est: 81.10B (+68.7%)
|
138.91B
est: 79.60B (+74.5%)
|
143.96B
est: 79.50B (+81.1%)
|
174.53B
est: 68.80B (+153.7%)
|
196.41B
est: 133.84B (+46.7%)
|
215.99B
est: 88.60B (+143.8%)
|
128.20B
128.20B – 128.20B
+44.7% YoY
|
138.00B
138.00B – 138.00B
+7.6% YoY
|
159.50B
159.50B – 159.50B
+15.6% YoY
|
175.20B
175.20B – 175.20B
+9.8% YoY
|
143.40B
143.40B – 143.40B
-18.2% YoY
|
| EBITDA |
46.47B
est: 29.93B (+55.2%)
|
49.22B
est: 35.27B (+39.6%)
|
42.12B
est: 35.77B (+17.8%)
|
47.71B
est: 37.99B (+25.6%)
|
42.07B
est: 40.35B (+4.3%)
|
37.73B
est: 22.26B (+69.5%)
|
26.31B
est: 21.85B (+20.4%)
|
46.65B
est: 21.82B (+113.8%)
|
45.47B
est: 18.89B (+140.8%)
|
49.18B
est: 54.41B (-9.6%)
|
67.70B
est: 36.02B (+88.0%)
|
52.12B
52.12B – 52.12B
+44.7% YoY
|
56.10B
56.10B – 56.10B
+7.6% YoY
|
64.84B
64.84B – 64.84B
+15.6% YoY
|
71.23B
71.23B – 71.23B
+9.8% YoY
|
58.30B
58.30B – 58.30B
-18.2% YoY
|
| EBIT |
41.00B
est: 25.62B (+60.0%)
|
43.28B
est: 30.18B (+43.4%)
|
36.25B
est: 30.61B (+18.4%)
|
41.38B
est: 32.51B (+27.3%)
|
35.31B
est: 34.53B (+2.2%)
|
30.83B
est: 19.05B (+61.8%)
|
19.81B
est: 18.70B (+5.9%)
|
39.78B
est: 18.68B (+113.0%)
|
38.90B
est: 16.16B (+140.7%)
|
42.98B
est: 54.00B (-20.4%)
|
61.39B
est: 35.75B (+71.7%)
|
51.73B
51.73B – 51.73B
+44.7% YoY
|
55.68B
55.68B – 55.68B
+7.6% YoY
|
64.36B
64.36B – 64.36B
+15.6% YoY
|
70.69B
70.69B – 70.69B
+9.8% YoY
|
57.86B
57.86B – 57.86B
-18.2% YoY
|
| Net Income |
25.91B
est: 20.11B (+28.8%)
|
28.62B
est: 23.55B (+21.5%)
|
26.31B
est: 24.07B (+9.3%)
|
28.37B
est: 25.75B (+10.2%)
|
23.32B
est: 20.92B (+11.5%)
|
22.28B
est: 20.09B (+10.9%)
|
13.50B
est: 16.47B (-18.0%)
|
26.44B
est: 25.26B (+4.6%)
|
27.93B
est: 24.34B (+14.8%)
|
31.13B
est: 32.12B (-3.1%)
|
43.90B
est: 39.87B (+10.1%)
|
57.37B
56.61B – 58.14B
+43.9% YoY
|
64.16B
62.19B – 66.12B
+11.8% YoY
|
70.62B
70.62B – 70.62B
+10.1% YoY
|
73.51B
73.51B – 73.51B
+4.1% YoY
|
76.21B
76.21B – 76.21B
+3.7% YoY
|
| SGA |
—
est: 35.75B (-100.0%)
|
24.45B
est: 42.11B (-41.9%)
|
24.17B
est: 42.71B (-43.4%)
|
23.72B
est: 45.36B (-47.7%)
|
23.46B
est: 48.18B (-51.3%)
|
23.08B
est: 26.58B (-13.2%)
|
22.71B
est: 26.09B (-13.0%)
|
22.15B
est: 26.06B (-15.0%)
|
22.09B
est: 22.55B (-2.0%)
|
22.04B
est: 13.46B (+63.8%)
|
23.76B
est: 8.91B (+166.7%)
|
12.89B
12.89B – 12.89B
+44.7% YoY
|
13.87B
13.87B – 13.87B
+7.6% YoY
|
16.03B
16.03B – 16.03B
+15.6% YoY
|
17.61B
17.61B – 17.61B
+9.8% YoY
|
14.42B
14.42B – 14.42B
-18.2% YoY
|
| EPS |
56.37
est: 52.15 (+8.1%)
|
63.78
est: 61.05 (+4.5%)
|
59.46
est: 62.40 (-4.7%)
|
65.27
est: 66.75 (-2.2%)
|
54.12
est: 54.24 (-0.2%)
|
52.79
est: 52.10 (+1.3%)
|
32.14
est: 42.70 (-24.7%)
|
63.33
est: 65.50 (-3.3%)
|
68.19
est: 63.10 (+8.1%)
|
78.43
est: 84.51 (-7.2%)
|
113.82
est: 104.90 (+8.5%)
|
150.95
148.94 – 152.96
+43.9% YoY
|
168.79
163.62 – 173.97
+11.8% YoY
|
185.80
185.80 – 185.80
+10.1% YoY
|
193.40
193.40 – 193.40
+4.1% YoY
|
200.50
200.50 – 200.50
+3.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C+ | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-11 | B- | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-08 | B- | 3/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-07 | B- | 3/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-01 | B- | 3/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-30 | B- | 3/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-28 | B- | 3/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-27 | B- | 3/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-24 | B | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | B | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | MUFG Japan Small Cap Active ETF MJSC | 1.65% | 376.4K | 0.85% |
| 2 | iShares MSCI Japan Small Cap UCITS ETF IDJP.L | 0.36% | 2.05M | 0.58% |
| 3 | iShares MSCI Japan Small-Cap ETF SCJ | 0.36% | 928.3K | 0.50% |
| 4 | iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ | 0.14% | 309.9K | 0.83% |
| 5 | iShares MSCI EAFE Small-Cap ETF SCZ | 0.14% | 18.67M | 0.40% |
| 6 | Avantis International Small Cap Value ETF AVDV | 0.13% | 23.76M | 0.36% |
| 7 | iShares Global Equity Factor ETF GLOF | 0.11% | 243.8K | 0.20% |
| 8 | Avantis International Small Cap Equity ETF AVDS | 0.11% | 351.4K | 0.30% |
| 9 | Franklin FTSE Japan Hedged ETF FLJH | 0.10% | 175.9K | 0.09% |
| 10 | Avantis International Large Cap Value ETF AVIV | 0.09% | 1.69M | 0.25% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akihiko Fukai | President & Representative Director | — | male |
| Akihiko Horie | MD, Director & General Manager of Corporate Consulting Headquarters | — | male |
| Akihiro Goto | Senior MD & Director | — | male |
| Hideko Tatsukawa | Executive Officer, GM of HR Management Department | — | — |
| Hiroyuki Irisawa | Executive Vice President & Director | — | male |
| Satomi Nagaoka | Managing Exe. Officer, GM of Examination Dept Area GM of Kumagaya, Omiya, Keihin & Osaka | — | — |
| Takashi Ishize | Managing Executive Officer & Area GM of Overseeing Ota, Kiryu, Tatebayashi & Tochigi Regions | — | — |
| Takeo Uchibori | Senior MD & Director | — | male |
| Tsutomu Takei | Senior MD & Director | — | male |
| Yasuaki Ishikawa | IR Contact (Senior Deputy General Manager) | — | male |
| Yuichi Sumidagawa | Executive Officer, GM, Head Office Sales Dept and GM of Soja Branch | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 8334.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
